GILEAD SCIENCES, INC.
FollowFiler group, 2 members, built by the linking rules
GILEAD SCIENCES, INC. is a filer group of 2 members, 2 of them filing 13F reports, with 8 filings between them.
Members
Each member with the evidence that put it in the group. A member counts only inside the quarters shown (method).
| Member | Kind | Quarters | Evidence |
|---|---|---|---|
| Gilead Therapeutics A1 Unlimited CoCIK 2055207 | 13F filer | from Q1 2026 |
|
| GILEAD SCIENCES, INC.CIK 882095 | 13F filer | all |
|
Filings of the group
The union of the members' filings: 13F reports and notices, 13D and 13G naming a member, and Forms 3, 4 and 5 with a member as reporting owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001123292-26-001034 | Quarter ended 2026-06-30 | 2026-08-03 | acceptance time not in the bulk data set | |
| 13F-NT 0001123292-26-001038 | Quarter ended 2026-06-30 | 2026-08-03 | acceptance time not in the bulk data set | |
| 13F-NT 0001123292-26-000643 | Quarter ended 2026-03-31 | 2026-05-08 | acceptance time not in the bulk data set | |
| 13F-HR 0001123292-26-000642 | Quarter ended 2026-03-31 | 2026-05-08 | acceptance time not in the bulk data set | |
| 13F-NT 0001123292-26-000165 | Quarter ended 2025-12-31 | 2026-02-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001123292-26-000164 | Quarter ended 2025-12-31 | 2026-02-12 | acceptance time not in the bulk data set | |
| 13F-HR 0001123292-25-000642 | Quarter ended 2025-09-30 | 2025-11-13 | acceptance time not in the bulk data set | |
| 13F-NT 0001123292-25-000641 | Quarter ended 2025-09-30 | 2025-11-13 | acceptance time not in the bulk data set |